Nasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
WBBM Radio Chicago on MSN7h
Mayor’s office rescinds COVID-19 vaccine mandate, ‘2 years too late’: police union president
The Fraternal Order of Police has been fighting the requirement since the Lightfoot administration imposed it in 2021.
Rappler2d
FACT CHECK: Post on alleged Pfizer COVID-19 vaccine side effects is false
Other fact-checking organizations have debunked the claim; Reuters and AFP have also fact-checked similar claims that circulated in 2022 and 2023 ...
CNN on MSN13d
NIH interim director comes from its research ranks but is known for questioning Covid-19 vaccine mandates
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
La Crosse Tribune6d
Development of an mRNA vaccine for Covid-19 was fast
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
What Has RFK Jr. Said About Covid-19?
Citing unverified data, Robert F. Kennedy Jr. claimed in December 2021 that the Covid-19 vaccine was the “deadliest vaccine ...
thecardiologyadvisor.com3d
COVID-19 Vaccine Confers Protection Against Post-COVID-19 Conditions
The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.
The Hill on MSN10d
Trump to reinstate military members dismissed over COVID-19 shot refusal
Service members dismissed from the military for failing to get vaccinated against COVID-19 will be reinstated with full back ...
psychiatryadvisor.com1d
Interviews ID Factors Tied to COVID-19 Vaccine Hesitancy in Black Women
(HealthDay News) — Three main themes may largely explain COVID-19 vaccine hesitancy among Black women in the United States: mistrust in health care and government, concerns over vaccine safety, and ...
EurekAlert!2d
Nasal COVID-19 vaccine based on WashU technology to enter US clinical trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...